ESOPHAGEAL NEOPLASMS
Clinical trials for ESOPHAGEAL NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new ESOPHAGEAL NEOPLASMS trials appear
Sign up with your email to follow new studies for ESOPHAGEAL NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Fish oil boosts immunotherapy in esophageal cancer trial
Disease control Recruiting nowThis study tests whether adding omega-3 fatty acids (EPA and DHA) to standard immunotherapy (PD-1 inhibitors) can improve muscle mass and overall outcomes in adults with advanced esophageal cancer. About 142 participants will receive either omega-3 or a placebo for 6 months along…
Matched conditions: ESOPHAGEAL NEOPLASMS
Phase: NA • Sponsor: Fudan University • Aim: Disease control
Last updated May 26, 2026 10:16 UTC
-
New antibody drug takes aim at Hard-to-Treat cancers
Disease control Recruiting nowThis trial tests a new drug called UCB4594, an antibody that targets a protein (HLA-G) found on many cancer cells. The goal is to see if it helps the immune system attack tumors. It is for people with advanced solid tumors (like lung, breast, or colon cancer) that have not respon…
Matched conditions: ESOPHAGEAL NEOPLASMS
Phase: PHASE1, PHASE2 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated May 26, 2026 10:12 UTC
-
Which surgery wins for junction cancer? new trial aims to find out
Disease control Recruiting nowThis study compares two surgeries—proximal gastrectomy and total gastrectomy—for people with locally advanced gastroesophageal junction cancer. About 120 adults aged 18 to 90 will be randomly assigned to one surgery type. The goal is to see which approach leads to better 3-year c…
Matched conditions: ESOPHAGEAL NEOPLASMS
Phase: NA • Sponsor: Nurettin Şahin • Aim: Disease control
Last updated May 26, 2026 10:12 UTC
-
New hope for stomach cancer patients: experimental drug combos enter trial
Disease control Recruiting nowThis study tests two new drug combinations for people with advanced stomach, gastroesophageal junction, or esophageal cancer that has worsened after initial treatment. About 210 participants will receive either an experimental antibody-drug conjugate plus standard chemotherapy, o…
Matched conditions: ESOPHAGEAL NEOPLASMS
Phase: PHASE1, PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 26, 2026 10:11 UTC
-
New hope for stomach cancer: experimental drug cocktail enters human trials
Disease control Recruiting nowThis study tests whether adding new investigational drugs to standard chemotherapy and immunotherapy (pembrolizumab) can safely shrink tumors in people with advanced stomach, gastroesophageal junction, or esophageal cancer that has not been treated before. About 160 adults whose …
Matched conditions: ESOPHAGEAL NEOPLASMS
Phase: PHASE1, PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
New radiation drug targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-stage study tests a new drug called LY4337713 in people with advanced cancers (like pancreatic, breast, ovarian, or colorectal) that have high levels of a protein called FAP. The drug delivers radiation directly to cancer cells. The main goals are to check safety, find…
Matched conditions: ESOPHAGEAL NEOPLASMS
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 19, 2026 11:48 UTC
-
New rehab program aims to boost quality of life for stomach and esophageal cancer patients.
Symptom relief Recruiting nowThis study is testing a structured rehabilitation program for 100 people in southern Sweden who have esophageal or stomach cancer and are scheduled for surgery. The goal is to see if the program can improve quality of life and reduce cancer-related symptoms. Participants will be …
Matched conditions: ESOPHAGEAL NEOPLASMS
Sponsor: Region Skane • Aim: Symptom relief
Last updated May 19, 2026 11:47 UTC
-
Bright light and exercise show promise for cancer Patients' sleep and mood
Symptom relief Recruiting nowThis study tests a 6-week program combining bright light exposure with specific exercises to improve sleep, mood, and quality of life in people with lung or esophageal cancer. Researchers will track 200 participants' sleep patterns, symptoms, and survival rates for one year. The …
Matched conditions: ESOPHAGEAL NEOPLASMS
Phase: NA • Sponsor: Taipei Veterans General Hospital, Taiwan • Aim: Symptom relief
Last updated May 18, 2026 12:06 UTC
-
Researchers review endoscopic removal of digestive tract tumors
Knowledge-focused Recruiting nowThis study reviews past medical records of 2,000 adults who had an endoscopic procedure to remove cancerous or precancerous growths in the esophagus, stomach, duodenum, colon, or rectum. The goal is to compare different removal techniques and see how well they work and how safe t…
Matched conditions: ESOPHAGEAL NEOPLASMS
Sponsor: Azienda USL Reggio Emilia - IRCCS • Aim: Knowledge-focused
Last updated May 26, 2026 10:11 UTC
-
New survey aims to improve care for esophageal patients
Knowledge-focused Recruiting nowThis study is collecting survey responses from 1,000 people who have had or will have surgery for esophageal cancer or other upper digestive problems. The goal is to create a standard way to measure symptoms and recovery after treatment. The information will help doctors better m…
Matched conditions: ESOPHAGEAL NEOPLASMS
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 26, 2026 10:10 UTC